Period prevalence of chronic pancreatitis diagnosis from 2001–2013 in the commercially insured population of the United States
Background Prevalence estimates of chronic pancreatitis (CP) in the US are scarce. We
aimed to determine the prevalence of CP in the commercially insured population of the US.
Methods We analyzed the IQVIA Legacy PharMetrics database to calculate the period
prevalence of CP from 2001 to 2013 among individuals with≥ 1 year of enrollment. CP was
defined as≥ 1 healthcare contacts associated with a non-ancillary claim for a primary
diagnosis of CP (ICD-9-CM 577.1). Prevalence estimates were age-and sex-adjusted to the …
aimed to determine the prevalence of CP in the commercially insured population of the US.
Methods We analyzed the IQVIA Legacy PharMetrics database to calculate the period
prevalence of CP from 2001 to 2013 among individuals with≥ 1 year of enrollment. CP was
defined as≥ 1 healthcare contacts associated with a non-ancillary claim for a primary
diagnosis of CP (ICD-9-CM 577.1). Prevalence estimates were age-and sex-adjusted to the …